Literature DB >> 8486161

A 31P NMR study of the interaction of the antitumor active metallocene Cp2MoCl2 with calf thymus DNA.

M M Harding1, G J Harden, L D Field.   

Abstract

Treatment of sonicated calf thymus DNA with the antitumor active metallocene Cp2MoCl2 afforded a metallocene-DNA complex which was characterized by 31P NMR spectroscopy. In addition to the resonance for the phosphate backbone (delta-1.6), the spectrum contained 2 signals assigned to a phosphate bound Mo-DNA complex(es) (delta 37.2, 36.5) and a broad signal at delta 6.2 ppm. This result suggests that covalent attachment of the metallocene Cp2MoCl2 occurs via phosphate(O) coordination and is accompanied by local distortion of the DNA backbone. This result supports recent ICP studies with Cp2TiCl2 that have DNA detected DNA-metallocene adducts.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8486161     DOI: 10.1016/0014-5793(93)81588-q

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  Specific Interactions of Antitumor Metallocenes with Deoxydinucleoside Monophosphates.

Authors:  Rahel P Eberle; Yvonne Hari; Stefan Schürch
Journal:  J Am Soc Mass Spectrom       Date:  2017-05-12       Impact factor: 3.109

2.  Bioorganometallic Chemistry of Molybdenocene Dichloride and Its Derivatives.

Authors:  Enrique Meléndez
Journal:  J Organomet Chem       Date:  2012-02-06       Impact factor: 2.369

3.  In Vitro Characterization of a Threonine-Ligated Molybdenyl-Sulfide Cluster as a Putative Cyanide Poisoning Antidote; Intracellular Distribution, Effects on Organic Osmolyte Homeostasis, and Induction of Cell Death.

Authors:  Johanna M Gretarsdottir; Ian H Lambert; Stefan Sturup; Sigridur G Suman
Journal:  ACS Pharmacol Transl Sci       Date:  2022-09-09

4.  Interaction of metallocene dichlorides with apo-human transferrin: A spectroscopic study and cytotoxic activity against human cancer cell lines.

Authors:  Jorge R Güette Fernández; Xiomara Narváez Pita; Enrique Meléndez; Elsie I Parés Matos
Journal:  Int J Mol Biol (Edmond)       Date:  2020-07-31

Review 5.  Organometallic anticancer compounds.

Authors:  Gilles Gasser; Ingo Ott; Nils Metzler-Nolte
Journal:  J Med Chem       Date:  2010-11-15       Impact factor: 7.446

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.